🆕 HOW TO MAKE A #DIAGNOSIS OF #LUPUS ?!? is the most common question 🧐 I get ➡️ Well, certainly NOT ⛔ by checking ✔️ if you have at least 4 criteria 📑 on a list ! #SLE diagnosis is a complex process 👨‍🎓 and requires expertise. Ask your #rheumatologist 👍 if you are unsure 🏥.

✅ What are the main goals of #Rheumatology specialists when treating systemic #Lupus in 2025? Our aim is mostly to attain - and then maintain - #remission, with many other favorable outcomes associated with this state👌the longer the better 🙏 #APLAR25

✅ Strikingly ~40% of all active investigational #trials in #SLE assess a type of cellular therapy, of which anti-CD19 #CART represents the highest proportion, among various other targets and and targeting constructs ⬇️ #APLAR25

✅ The current drug pipeline for #LUPUS is very promising! ➡️ Of the 817 investigational trials registered for #lupus at https://t.co/QulyZDQItB, 183 are currently ACTIVE and 69% of those are for #SLE (vs LN or CLE), with 50+ investigational agents being assessed 👌

✅ Little teaser QUIZZ before this afternoon session about new #treatments in #SLE at #APLAR25. Can you guess which proportion of ONGOING TRIALS in systemic #Lupus are now CELLULAR THERAPIES (Including #CART cells, CAR-NK etc)?

✅ Don't miss our #APLAR25 session about new #treatments for systemic #Lupus ⬇️ on 5 September 2025, from 16:55 pm to 18:10 pm 😁 It's going to be amazing session, together with Prs. Marta Mosca and Andrea Doria 👍

Learn from global SLE experts at #APLAR25 on 5 September 2025, from 16:55 pm to 18:10 pm. Prof. Arnaud, Dr. Mosca and Prof. Doria will explore new therapies, updated recommendations and key complications in #SLE care. View the full program: https://t.co/Sois2r5eD3

✅ We have at least 15+ treatments usable in systemic #Lupus (and some of those approved in other indications in #Rheumatology - below in grey - can be used) but everybody agrees that we can do better. At #APLAR2025, I will focus on what we expect from NEW TREATMENTS in #SLE 👍

✅ What are we expecting from NEW (future?) treatments for systemic #Lupus? ⬇️ #APLAR2025 What else can you think of?

✅ Check #EULAR #recommendations for a core #dataset to support clinical care and translational and observational research in systemic #lupus erythematosus 📥 DOWNLOAD LINK: https://t.co/bBDAKK4g0J

✅ Who is (also) going to @APLAR_org 2025 Meeting in Fukuoka (3-7 Sept 2025)? #Rheumatology #Lupus

📢 New in Aut Rev! Together with @G_O_Daniel & @Lupusreference, we have reviewed 10 years of studies on SDH in #SLE. This narrative review maps disparities across the patient pathway and offers solutions at each step. From first symptoms to outcomes https://t.co/QkW1UeyZRy

📢 Our new paper is out in Autoimmunity Reviews! We review how social determinants of health #SDH shape outcomes in #lupus — across the full patient journey — and explore solutions. Huge thank you to Zoe & Lena from @LupusEurope and @Lupusreference ! 🔗 https://t.co/Jzdgv8R3Z8

✅ What is lacking the most at the #lupus consultation, from the #patient perspective? OPEN-ACCESS FREE LINK: https://t.co/ti7MeHo1sW

Great news!! Our paper with the results of our Living With SLE in Europe: Swiss Knife Survey is out! Thanks @Lupusreference for your amazing support! Thanks also @sarahdyball1 @G_O_Daniel @cristianasieiro @elis_chessa @jeanette_lupus @ricky_chotai @tulupus @AnnemarieS66 et al!

✅ #PrecisionMedicine is IMPORTANT in #Lupus, but PERSONALIZED medicine, - taking into account the personal socio-economic determinants & patient #vulnerabilities-, is even MORE IMPORTANT. Check our latest PAPER with @G_O_Daniel & Zoe from @LupusEurope at: https://t.co/OXq9YGUddD

✅ Happy to report that our recent paper "Experiences and unmet needs of persons living with systemic #lupus erythematosus in Europe: Lupus Europe's 2024 Swiss knife survey" with @LupusEurope is now #openaccess 🔓 for all 👍 https://t.co/ti7MeHo1sW

✅ Very happy to report that we have completed the #LBFSS study STEP2!! An international panel of experts 🧑‍🎓 & patients(-representatives) from @LupusEurope have triaged the #lupus #brainfog domains from step 1 and selected those relevant for inclusion in the #LBFSS questionnaire!

✅ Very happy to report that we have completed the entiere STEP1 of #ENDORSED, the international #consensus definition of #SEVERE #LUPUS by the #DORIS group gathering 50+ potential facets of severity thanks to the international panel of HCPs (step 1a) and patients (step 1b) 👍

✅ Using #ChatGPT to generate a POST-#EULAR2025 summary about #Lupus ⬇️ how did I do that?!? I performed a search for 'lupus' in the online program of the congress🔎 copy-pasted the results in chatGPT and used it to perform a 'thematic analysis' on the results 💪👍 FASCINATING

✅ Thank you @LupusCanada for your post about our work #SLAKE ⬇️